VERU – State Reviewer

Rating Indicators

VERU Stock: Few Reasons To Be Better

Veru Inc. (NASDAQ: VERU) revealed the findings of phase III trials of antiviral medication for patients with severe COVID-19. In clinical studies, the sabizabulin candidate

Stock Earnings

VERU: Top attractive stock of the week

In trading on June 7, shares of biotech business Veru Inc. (NASDAQ: VERU) surged 16.8 percent to $15.85. VERU, which has a market valuation of

Industry

The Thing That Hid Veru Inc. (NASDAQ:VERU)’s Strength

Veru Inc. (NASDAQ:VERU) has a beta of 0.61. The stock’s Relative Strength Index (RSI) is 48.51, with weekly volatility at 3.78% and ATR at 0.39.

Markets

The Futility of Veru Inc. (NASDAQ:VERU)’s Fundamentals

Veru Inc. (NASDAQ:VERU) Relative Strength Index (RSI) is 55.74, with weekly volatility at 4.79% and ATR at 0.51. The VERU stock’s 52-week price range has

Industry

Veru Inc. (NASDAQ:VERU) moved up 2.12% in a month: Spotting A Buy Candidate

Veru Inc. (NASDAQ:VERU) Relative Strength Index (RSI) is 58.24, with weekly volatility at 4.64% and ATR at 0.52. The VERU stock’s 52-week price range has

Finance

Why To Keep Buying Veru Inc. (NASDAQ:VERU) while S&P500 gain 0.05%

Veru Inc. (NASDAQ:VERU) shares traded higher over the last trading session, gaining 1.97% on 05/27/21. The shares fell to a low of $8.46 before closing

Tag: VERU

VERU Stock: Few Reasons To Be Better

VERU: Top attractive stock of the week

The Thing That Hid Veru Inc. (NASDAQ:VERU)’s Strength

The Futility of Veru Inc. (NASDAQ:VERU)’s Fundamentals

Veru Inc. (NASDAQ:VERU) moved up 2.12% in a month: Spotting A Buy Candidate

Why To Keep Buying Veru Inc. (NASDAQ:VERU) while S&P500 gain 0.05%

Quick Links

Categories